Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Mitchell H. Sokoloff"'
Autor:
Daniel M Frendl, Gordon FitzGerald, Mara M Epstein, Jeroan J Allison, Mitchell H Sokoloff, John E Ware
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0240039 (2020)
ObjectiveTo develop a tool for estimating the 10-year risk of death from other causes in men with localized prostate cancer.Subjects and methodsWe identified 2,425 patients from the Surveillance Epidemiology and End Results-Medicare Health Outcomes S
Externí odkaz:
https://doaj.org/article/1bb795593abc4ec8beef99e12fbd405e
Autor:
Paulo N. Martins, Jennifer Yates, Babak Movahedi, Adel Bozorgzadeh, Mitchell H. Sokoloff, Zachary G. Papazian, Kenneth A. Bodziak, Anthony P. Tran, Vijay K. Vanguri, Pang-Yen Fan
Publikováno v:
Experimental and Clinical Transplantation. 19:732-735
With the rising incidence of end-stage renal disease in the United States, patients needing renal transplants are waiting longer for increasingly scarce grafts. Formerly, the general practice was to avoid organs with tumors for transplant because of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6653713477c4de6a0386a890abd9173c
https://doi.org/10.6002/ect.2018.0215
https://doi.org/10.6002/ect.2018.0215
Autor:
Marcus Ruscetti, Tao Wang, Mitchell H. Sokoloff, Ameer L. Elaimy, Kriti Mittal, Brian C. Lewis, Thomas J. Fitzgerald
Publikováno v:
Prostate Cancer ISBN: 9780645001754
Adenocarcinoma of the prostate is a common malignancy affecting one in nine men, with six of every 10 cases identified in men older than 66 years, and more adversely affects African American males. It remains less common in men under the age of 40. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8971c09bb942c4afc30b5e025c45234
https://doi.org/10.36255/exonpublications.prostatecancer.translationalscience.2021
https://doi.org/10.36255/exonpublications.prostatecancer.translationalscience.2021
Autor:
Gordon FitzGerald, Mara M. Epstein, Daniel M. Frendl, John E. Ware, Jeroan J. Allison, Mitchell H. Sokoloff
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0240039 (2020)
ObjectiveTo develop a tool for estimating the 10-year risk of death from other causes in men with localized prostate cancer.Subjects and methodsWe identified 2,425 patients from the Surveillance Epidemiology and End Results—Medicare Health Outcomes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::744212d362aec4b0b73ab81c5fa1986d
https://pubmed.ncbi.nlm.nih.gov/33792371
https://pubmed.ncbi.nlm.nih.gov/33792371
Autor:
Traci M. Blonquist, Fangxin Hong, Randy A. Jones, Julia H. Hayes, Niya Xiong, Peter Chang, Barbara Halpenny, Christopher P. Filson, Quoc-Dien Trinh, Leslie Wilson, Viraj A. Master, Mitchell H. Sokoloff, Donna L. Berry, Tracey L. Krupski, Martin G. Sanda, Gary W. Chien, Seth Wolpin
Publikováno v:
Urol Oncol
INTRODUCTION: Men diagnosed with localized prostate cancer must navigate a highly preference-sensitive decision between treatment options with varying adverse outcome profiles. We evaluated whether use of a decision support tool previously shown to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2349b31d75cd2eb56ac1c529f28d91f
https://doi.org/10.1016/j.urolonc.2020.11.038
https://doi.org/10.1016/j.urolonc.2020.11.038
Autor:
Miller As, Mitchell H. Sokoloff, Roger Luckmann, Mara M. Epstein, Daniel M. Frendl, Jennifer Fantasia, Jennifer Yates, Achankeng Afiadata
Publikováno v:
Urology Practice. 4:126-131
Introduction Prostate specific antigen use in prostate cancer screening has undergone significant changes since the 2012 release of the USPSTF (United States Preventive Services Task Force) guideline statement. The effect on specific primary care pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aabd9962cab428256a3631bf1eb3f378
https://doi.org/10.1016/j.urpr.2016.04.003
https://doi.org/10.1016/j.urpr.2016.04.003
Autor:
Richard Krajenta, Mara M. Epstein, Mitchell H. Sokoloff, Hassan Fouayzi, Daniel M. Frendl, Benjamin A. Rybicki
Publikováno v:
Cancer Causes Control
PURPOSE: This study describes longitudinal trends in the use of prostate-specific antigen (PSA)- based testing in two geographically-distinct healthcare systems following the 2011 US Preventive Services Task Force (USPSTF) recommendations against rou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13e006530785911aec4f1af48fbbcb49
https://pubmed.ncbi.nlm.nih.gov/32556947
https://pubmed.ncbi.nlm.nih.gov/32556947
Autor:
Mitchell H. Sokoloff, Jennifer Yates
Publikováno v:
Urology Practice. 6:315-316
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a74d9d271f9de0afcd646d02cd9e4534
https://doi.org/10.1097/01.upj.0000580740.32272.72
https://doi.org/10.1097/01.upj.0000580740.32272.72
Autor:
Leslie Wilson, Seth Wolpin, Mitchell H. Sokoloff, Tracey L. Krupski, Peter Chang, Quoc-Dien Trinh, Christopher P. Filson, Randy A. Jones, Julia H. Hayes, Traci M. Blonquist, Viraj A. Master, Donna L. Berry, Fangxin Hong, Gary W. Chien, Prabhakara Somayaji, Martin G. Sanda, Barbara Halpenny
Publikováno v:
The Journal of urology, vol 199, iss 1
PurposeWe evaluated the efficacy of the web based P3P (Personal Patient Profile-Prostate) decision aid vs usual care with regard to decisional conflict in men with localized prostate cancer.Materials and methodsA randomized (1:1), controlled, paralle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c39e38b46b73c7d2339455dbda3972fe
https://pubmed.ncbi.nlm.nih.gov/29555541
https://pubmed.ncbi.nlm.nih.gov/29555541
Autor:
Robert S. Krouse, Jessica A. Martinez, Blake A. Gibson, Chiu Hsieh Hsu, Catherine A. Cordova, Mike M. Nguyen, Raymond B. Nagle, H-H. Sherry Chow, Mitchell H. Sokoloff, Howard L. Parnes
Publikováno v:
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP). 27(6)
Metformin has recently been shown to have potential to reduce prostate cancer risk. We conducted a randomized, double-blind, placebo-controlled trial to determine the modulating effects of metformin on tissue and systemic biomarkers of drug activity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::549cb7a1f866b92762e798eab3bcd3b9
https://pubmed.ncbi.nlm.nih.gov/28692586
https://pubmed.ncbi.nlm.nih.gov/28692586